Molecular mechanics force fields and their applications in drug design

Anti-Infective Agents in Medicinal Chemistry

Volumn 8, Issue 2, 2009, Pages 128-150

  Pissurlenkar, Raghuvir R S ^a   Shaikh, Mushtaque S ^a   Iyer, Radhakrishnan P ^a,b   Coutinho, Evans C ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

^b Spring Bank Pharmaceuticals Inc S 7   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDYL) 1H INDOLE; AMINOPTERIN; BUFOTENINE; CYCLOOXYGENASE 2 INHIBITOR; IPSAPIRONE; KITANSERINE; L 685 434; METHOTREXATE; PROTEINASE INHIBITOR; PYRIMETHAMINE; PYRIMETHAMINE DERIVATIVE; SAQUINAVIR; SPIPERONE; SPIROCATRINE; TRYPTAMINE DERIVATIVE; UNCLASSIFIED DRUG;

ACCURACY; BINDING AFFINITY; CALCULATION; DRUG BINDING SITE; DRUG DESIGN; DRUG RECEPTOR BINDING; DRUG STRUCTURE; ENZYME BINDING; HYDROGEN BOND; MOLECULAR DOCKING; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; MOLECULAR MODEL; PHARMACOPHORE; POLARIZATION; PROCESS OPTIMIZATION; PROTEIN CONFORMATION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; SCORING SYSTEM;

EID: 67651099143     PISSN: 18715214     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152109787846088     Document Type: Review

References (185)

1. Lifson, S.; Warshel, A. Consistent Force Field for Calculations of Conformations, Vibrational Spectra, and Enthalpies of Cycloalkane and n-Alkane Molecules. J. Chem. Phys., 1968, 49, 5116-29.
2. Andrews, D. H. The Relation between the Raman Spectra and the Structure of Organic Molecules. Phys. Rev., 1930, 6, 544-54.
3. de la Mare, P.; Fowden, L.; Hughes, E. D.; Ingold, C. K.; Mackie, J. Mechanism of substitution at a saturated carbon atom. Part XLIX. Analysis of steric and polar effects of alkyl groups in bimolecular nucleophilic substitution, with special reference to halogen exchanges. J. Chem. Soc., 1955, 3200, XLIX.
4. Dostrosky, I.; Hughes, E. D.; Ingold, C. K. Mechanism of substitution at a saturated carbon atom. Part XXXII. The rôle of steric hindrance. (Section G) magnitude of steric effects, range of occurrence of steric and polar effects, and place of the wagner rearrangement in nucleophilic substitution and elimination. J. Chem. Soc., 1946, 173, XXXII.
5. Westheimer, F. H.; Meyers, J. E. The Theory of the Racemization of Optically Active Derivatives of Diphenyl. J. Chem. Phys., 1946, 14, 733.
6. Westheimer, F. H. A Calculation of the Energy of Activation for the Racemization of 2,2-Dibromo-4,4-Dicarboxydiphenyl. J. Chem. Phys., 1947, 15, 252.
7. Westheimer, F. H. In Steric Effects in Organic Chemistry; Newman, M. S., Ed. Wiley: New York, 1956.
8. Machida, K. Principles of Molecular Mechanics. John Wiley & Sons: 1999.
9. Rappe, A. K.; Casewit, C. J. Molecular Mechanics across Chemistry. University Science Books: New York, 1996.
10. Hehre, W. J. A Guide to Molecular Mechanics and Quantum Chemical Calculations. Wavefunction, Inc.: Irvine, CA, 2003.
11. Hatmann, M. In Burkert, U.; Allinger, N. L., Eds.; American Chemical Society.: Washington, D.C.U.S.A., 1982.
12. Ramachandran, G. N.; Sasisekharan, V. Conformation of polypeptides and proteins. Adv. Protein Chem., 1968, 23, 283-437.
13. Karplus, M.; Evanseck, J. D.; Joseph, D.; Bash, P. A.; Field, M. J. Simulation analysis of triose phosphate isomerase: conformational transition and catalysis. Faraday Discuss, 1992, 239-48.
14. Karplus, M.; McCammon, J. A. Dynamics of proteins: elements and function. Annu. Rev. Biochem., 1983, 52, 263-300.
15. Karplus, P. A. Experimentally observed conformation-dependent geometry and hidden strain in proteins. Protein Sci., 1996, 5, 1406-20.
16. Wang, W.; Donini, O.; Reyes, C. M.; Kollman, P. A. Biomolecular simulations: Recent Developments in Force Fields, Simulations of Enzyme Catalysis, Protein-Ligand, Protein-Protein, and Protein-Nucleic Acid Noncovalent Interactions. Annu. Rev.Biophys. Biomol. Struct., 2001, 30, 211-43.
17. Momany, F. A.; McGuire, R. F.; Burgess, A. W.; Scheraga, H. A. Energy parameters in polypeptides. VII. Geometric parameters, partial atomic charges, nonbonded interactions, hydrogen bond interactions, and intrinsic torsional potentials for the naturally occurring amino acids. J. Phys. Chem., 1975, 79, 2361-81.
18. Scheraga, H. A. Calculations of conformations of polypeptides. Adv. Phys. Org. Chem., 1968, 6, 103.
19. Nemethy, G.; Pottle, M. S.; Scheraga, H. A. Energy Paramters in Polypeptides, 9. Updating of Geometrical Parameters, Nonbonding Interactions and Hydrogen Bonding Interactions for Naturally Occuring Amino Acids. J. Phys. Chem., 1983, 87, 1883-87.
20. Sippl, M. J.; Nemethy, G.; Scheraga, H. A. Intermolecular potentials from crystal data. 6. Determination of empirical potentials for O-H...O = C hydrogen bonds from packing configurations. J. Phys. Chem., 1984, 88, 6231-33.
21. Arnautova, Y. A.; Jagielska, A.; Scheraga, H. A. A new force field (ECEPP-05) for peptides, proteins, and organic molecules. J. Phys. Chem. B, 2006, 110, 5025-44.
22. Jagielska, A.; Arnautova, Y. A.; Scheraga, H. A. Derivation of a New Force Field for Crystal-Structure Prediction Using Global Optimization: Nonbonded Potential Parameters for Amines, Imidazoles, Amides, and Carboxylic Acids. J. Phys. Chem. B., 2004, 108, 12181-96.
23. Arnautova, Y. A.; Jagielska, A.; Pillardy, J.; Scheraga, H. A. Derivation of a new force field for crystal-structure prediction using global optimization: Nonbonded potential parameters for hydrocarbons and alcohols." J. Phys. Chem. B, 2003, 107, 7143-54.
24. Allinger, N. L. Conformational Analysis 130. MM2. A Hydrocarbon Force Field Utilizing V1 and V2 Torsional Terms. J. Am. Chem. Soc., 1977, 99, 8127-34.
25. Allinger, N. L.; Kok, R. A.; Imam, M. R. Hydrogen Bonding in MM2. J. Comput. Chem., 1988, 9, 591-95.
26. Lii, J.-H.; Gallion, S.; Bender, C.; Wikstrom, H.; Allinger, N. L.; Flurchick, K. M.; Teeter, M. M. Molecular Mechanics (MM2) "Calculations on Peptides and on the Protein Crambin Using the Cyber 205. J. Comput. Chem., 1989, 10, 503-13.
27. Allinger, N. L.; Yuh, Y. H.; Lii, J.-H. Molecular Mechanics. The MM3 Force Field for Hydrocarbons. 1. J. Am. Chem. Soc., 1989, 111, 8551-65.
28. Allinger, N. L.; Yuh, Y. H.; Lii, J.-H. Molecular Mechanics. The MM3 Force Field for Hydrocarbons. 2. Vibrational Frequencies and Thermodynamics. J. Am. Chem. Soc., 1989, 111, 8566-75.
29. Allinger, N. L.; Yuh, Y. H.; Lii, J.-H. Molecular Mechanics. The MM3 Force Field for Hydrocarbons. 3. The Van der Waals' Potentials and Crystal Data for Aliphatic and Aromatic Hydrocarbons. J. Amer. Chem. Soc., 1989, 111, 8576-82.
30. Lii, J.-H.; Allinger, N. L. The MM3 Force Field for Amides, Polypeptides and Proteins. J. Comput. Chem., 1991, 12, 186-99.
31. Hay, B. P.; Yang, L.; Lii, J.-H.; Allinger, N. L. An extended MM3(96) force field for complexes of the group 1A and 2A cations with ligands bearing conjugated ether donor groups. J. Mol. Struct: Theochem., 1998, 428, 203-19.
32. Brandt, P.; Norrby, T.; Akermark, B.; Norrby, P. O. Molecular Mechanics (MM3) Parameters for Ruthenium(II)-Polypyridyl Complexes. Inorg. Chem., 1998, 37, 4120-27.
33. Yoshida, T.; Sakakibara, K.; Asami, M.; Chen, K. H.; Lii, J. H.; Allinger, N. L. Molecular mechanics (MM3) calculations on lithium amide compounds. J. Comput. Chem., 2003, 24, 319-27.
34. Kirschner, K. N.; Lewin, A. H.; Bowen, J. P. Molecular mechanics force-field development for amino acid zwitterions. J. Comput. Chem., 2003, 24, 111-28.
35. Lii, J.-H.; Allinger, N. L. Directional Hydrogen Bonding in the MM3 Force Field. II. J. Comput. Chem., 1998, 19, 1001-16.
36. Allinger, N. L.; Chen, K.; Lii, J.-H. An Improved Force Field (MM4) for Saturated Hydrocarbons. J. Comput. Chem., 1996, 17, 642-68.
37. Allinger, N. L.; Chen, K.; Katzenellenbogen, J. A.; R., W. a. S.; Anstead, G. M. Hyperconjugative Effects on Carbon-Carbon Bond Lengths in Molecular Mechanics (MM4). J. Comput. Chem., 1996, 17, 747-55.
38. Allinger, N. L.; Fan, Y. Molecular Mechanics Studies (MM4) of Sulfides and Mercaptans. J. Comput. Chem., 1997, 18, 1827-47.
39. Chen, K. H.; Lii, J. H.; Walker, G. A.; Xie, Y.; Schaefer, H. F., 3rd; Allinger, N. L. Molecular mechanics (MM4) study of fluorinated hydrocarbons. J. Phys. Chem. A, 2006, 110, 7202-27.
40. Chen, K. H.; Lii, J. H.; Fan, Y.; Allinger, N. L. Molecular mechanics (MM4) study of amines. J. Comput. Chem., 2007, 28, 2391-412.
41. Nevins, N.; Chen, K.; Allinger, N. L. Molecular mechanics (MM4) calculations on alkenes. J. Comput. Chem., 1996, 17, 669-94.
42. Nevins, N.; Lii, J.-H.; Allinger, N. L. Molecular mechanics (MM4) calculations on conjugated hydrocarbons. J. Comput. Chem., 1996, 17, 695-729.
43. Mayo, S. L.; Olafson, B. D.; Goddard-III, W. A. Dreiding: a generic force field for molecular simulations. J. Phys. Chem., 1990, 94, 8897-909.
44. Rappe, A. K.; Casewit, C. J.; Colwell, K. H.; Goddard III, W. A.; Skiff, W. M. UFF, a full periodic table force field for molecular mechanics and molecular dynamics simulations. J. Am. Chem. Soc., 1992, 114, 10024-35.
45. Staerk, D.; Norrby, P. O.; Jaroszewski, J. W. Conformational analysis of indole alkaloids corynantheine and dihydrocorynantheine by dynamic 1H NMR spectroscopy and computational methods: steric effects of ethyl vs vinyl group. J. Org. Chem., 2001, 66, 2217-21.
46. Alcaro, S.; Ortuso, F.; Gallelli, A.; Battaglia, D.; Tafi, A.; Botta, M. Conformational search of antisense nucleotides. Part 2. Farmaco, 2004, 59, 169-73.
47. Halgren, T. A. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J. Comput. Chem., 1996, 17, 490-519.
48. Halgren, T. A. Merck molecular force field. II. MMFF94 van der Waals and electrostatic parameters for intermolecular interactions. J. Comput. Chem., 1996, 17, 520-52.
49. Halgren, T. A. Merck molecular force field. III. Molecular geometries and vibrational frequencies for MMFF94. J. Comput. Chem., 1996, 17, 553-86.
50. Halgren, T. A.; Nachbar, R. B. Merck molecular force field. IV. conformational energies and geometries for MMFF94. J. Comput. Chem., 1996, 17, 587-615.
51. Halgren, T. A. Merck Molecular Force Field. V. Extension of MMFF94 using Experimental Data, Additional Computational Data and Empirical Rules. J. Comput. Chem., 1996, 17, 616-41.
52. Damm, W.; Frontera, A.; Tirado-Rives, J.; Jorgensen, W. L. OPLS All-Atom Force Field for Carbohydrates. J. Comput. Chem., 1997, 18, 1955-70.
53. Jorgensen, W. L.; Maxwell, D. S.; Tirado-Rives., J. Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids. J. Am. Chem. Soc., 1996, 118, 11225.
54. Jorgensen, W. L.; Tirado-Rives, J. The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. J. Am. Chem. Soc., 1988, 110, 1657-66.
55. Mahoney, M. W.; Jorgensen, W. L. A five-site model for liquid water and the reproduction of the density anomaly by rigid, nonpolarizable potential functions. J. Chem. Phys., 2000, 112, 8910-22.
56. Kaminski, G.; Duffy, E. M.; Matsui, T.; Jorgensen, W. L. Free Energies of Hydration and Pure Liquid Properties of Hydrocarbons from the OPLS All-Atom Model. J. Phys. Chem., 1994, 98, 13077.
57. Brooks, B. R.; Bruccoleri, R. E.; Olafson, B. D.; States, D. J.; Swaminathan, S.; Karplus, M. A Program for Macromolecular Energy Minimization, and Dynamics Calculations. J. Comput. Chem., 1983, 4, 187-217.
58. Schleyer, P. v. R. In: The Encyclopedia of Computational Chemistry; A. D. MacKerell, J., B. Brooks, C. L. Brooks, III, L. Nilsson, B. Roux, Y. Won, and M. Karplus, Eds. John Wiley & Sons, Ltd.: Chichester, 1998; Vol. 1, pp. 271-77.
59. Feller, S. E.; Yin, D.; Pastor, R. W.; MacKerell, A. D., Jr. Molecular dynamics simulation of unsaturated lipid bilayers at low hydration: parameterization and comparison with diffraction studies. Biophys. J., 1997, 73, 2269-79.
60. Olson, L. P.; Luo, J.; Almarsson, O.; Bruice, T. C. Mechanism of aldehyde oxidation catalyzed by horse liver alcohol dehydrogenase. Biochemistry, 1996, 35, 9782-91.
61. Mackerell, A. D.; Wiorkiewiczkuczera, J.; Karplus, M. An all-atom empirical energy function for the simulation of nucleic acids. J. Am. Chem. Soc., 1995, 117, 11946-75.
62. Mackerell, D.; Bashford, D.; Bellott, M.; Dunbrack, R. L.; Evanseck, J. D.; Field, M. J.; Fischer, S.; Gao, J.; Guo, H.; Ha, S.; Joseph-Mccarthy, D.; Kuchnir, L.; Kuczera, K.; Lau, F. T. K.; Mattos, C.; Michnick, S.; Ngo, T.; Nguyen, D. T.; Prodhom, B.; Reiher, W. E.; Roux, B.; Schlenkrich, M.; Smith, J. C.; Stote, R.; Straub, J.; Watanabe, M.; Wiorkiewicz-Kuczera, J.; Yin, D.; M., K. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J. Phys. Chem. B, 1998, 102, 3586.
63. Pavelites, J. J.; Gao, J.; Bash, P. A.; MacKerell Jr., A. D. A molecular mechanics force field for NAD+ NADH, and the pyrophosphate groups of nucleotides. J. Comput. Chem., 1997, 18, 221-39.
64. Reiling, S.; Schlenkrich, M.; Brickmann, J. Force field parameters for carbohydrates. J. Comput. Chem., 1996, 17, 450-68.
65. Cournia, Z.; Smith, J. C.; Ullmann, G. M. A molecular mechanics force field for biologically important sterols. J. Comput. Chem., 2005, 26, 1383-99.
66. Weiner, P. K.; Kollman, P. A. AMBER: Assisted Model Building with Energy Refinement. A General Program for Modeling Molecules and Their Interactions. J. Comput. Chem., 1981, 2, 287-303.
67. Kollman, P.; Weiner, P.; Dearing, A. Studies of nucleotide conformations and interactions. The relative stabilities of double-helical B-DNA sequence isomers. Biopolymers, 1981, 20, 2583-621.
68. Blaney, J. M.; Weiner, P. K.; Dearing, A.; Kollman, P. A.; Jorgensen, E. C.; Oatley, S. J.; Burridge, J. M.; Blake, C. C. F. Molecular mechanics simulation of protein-ligand interactions: binding of thyroid hormone analogs to prealbumin. J. Am. Chem. Soc., 1982, 104, 6424-34.
69. Wipff, G.; Dearing, A.; Weiner, P. K.; Blaney, J. M.; Kollman, P. A. Molecular mechanics studies of enzyme-substrate interactions: the interaction of L- and D-N-acetyltryptophanamide with - chymotrypsin. J. Am. Chem. Soc., 1983, 105, 997-1005.
70. Weiner, S. J.; Kollman, P.; Case, D. A.; Singh, U. C.; Ghio, C.; Alagona, G.; Profeta, S.; Weiner, P. A new force field for molecular mechanical simulation of nucleic acids and proteins. J. Am. Chem. Soc., 1984, 106, 765-84.
71. Weiner, S. J.; Kollman, P.; Nguyen, D. T.; Case, D. A. An all atom force field for simulations of proteins and nucleic acids. J. Comput. Chem., 1986, 7, 230-52.
72. Veal, J. M.; Wilson, W. D. Modeling of nucleic acid complexes with cationic ligands: a specialized molecular mechanics force field and its application. J. Biomol. Struct. Dyn., 1991, 8, 1119-45.
73. Cornell, W. D.; Cieplak, P.; Bayly, C. I.; Gould, I. R.; Merz, K. M. J.; Ferguson, D. M.; Spellmeyer, D. C.; Fox, T.; Caldwell, J. W.; Kollman, P. A. A second generation force field for the simulation of proteins and nucleic acids. J. Am. Chem. Soc., 1995, 117, 5179-97.
74. Beachy, M. D.; Chasman, D.; Murphy, R. B.; Halgren, T. A.; Friesner, R. A. Accurate ab initio quantum chemical determination of the relative energetics of peptide conformations and assessment of empirical force fields. J. Am. Chem. Soc., 1997, 119, 5908-20.
75. Pearlman, D. A.; Case, D. A.; Caldwell, J. W.; Ross, W. S.; Cheatham, T. E. r.; DeBolt, S.; Ferguson, D.; Seibel, G.; Kollman, P. AMBER, A package of coputer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free enernergy calculation. Comput. Phys. Commun., 1995, 91, 1.
76. Kollman, P. A. Advances and Continuing Challenges in Achieving Realistic and Predictive Simulations of the Properties of Organic and Biological Molecules. Acc. Chem. Res., 1996, 29, 461-69.
77. Kollman, P.; Dixon, R.; Cornell, W.; Fox, T.; Chipot, C.; Pohorille, A. In: Computer Simultation of Biomolecules Systems; van Gunsteren, W. F.; Weiner, P. K.; Wilkinson, A. J., Eds.; Kluwer Academic Publishers Netherlands, 1997; Vol. 3, pp. 83-96.
78. Cheatham III, T. E.; Cieplak, P.; Kollman, A. A modified version of the Cornell et al.force field with improved sugar pucker phases and helical repeat. J. Biomol. Struct. Dyn., 1999, 16, 845-62.
79. Wang, J.; Cieplak, P.; Kollman, P. A. How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? J. Comput. Chem., 2000, 21, 1049-74.
80. Hornak, V.; Abel, R.; Okur, A.; Strockbine, B.; Roitberg, A.; Simmerling, C. Comparison of Multiple Amber Force Fields and Development of Improved Protein Backbone Parameters. Proteins: Struct., Funct. Bioinform., 2006, 65, 712-25.
81. Duan, Y.; Wu, C.; Chowdhury, S.; Lee, M. C.; Xiong, G.; Zhang, W.; Yang, R.; Cieplak, P.; Luo, R.; Lee, T.; Caldwell, J.; Wang, J.; Kollman, P. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J. Comput. Chem., 2003, 24, 1999-2012.
82. Yang, L.; Tan, C. H.; Hsieh, M. J.; Wang, J.; Duan, Y.; Cieplak, P.; Caldwell, J.; Kollman, P. A.; Luo, R. New-generation amber united-atom force field. J. Phys. Chem. B., 2006 110, 13166-76.
83. Wang, J.; Wolf, R. M.; Caldwell, J. W.; Kollman, P. A.; Case, D. A. Development and testing of a general amber force field. J. Comput. Chem., 2004, 25, 1157-74.
84. Hermans, J.; Berendsen, H. J. C.; van Gunsteren, W. F.; Postma, J. P. M. A Consistent Empirical Potential for Water-Protein Interactions. Biopolymers, 1984, 23, 1.
85. Christen, M.; Hünenberger, P. H.; Bakowies, D.; Baron, R.; Bürgi, R.; Geerke, D. P.; Heinz, T. N.; Kastenholz, M. A.; Kräutler, V.; Christine, C. O.; Trzesniak, P. D.; van Gunsteren, W. F. The GROMOS software for biomolecular simulation: GROMOS05. J. Comput. Chem., 2005, 26, 1719-51.
86. Suardiaz, R.; Maestre, M.; Suárez, E.; Pérez, C. Parameterization and validation of Gromos force field to use in conformational analysis of epoxidic systems. J. Mol. Struct: Theochem., 2006, 778, 21.
87. Lins, R. D.; Hünenberger, P. H. A new GROMOS force field for hexopyranose-based carbohydrates. J. Comput. Chem., 2005, 26, 1400-12.
88. Ott, K.-H.; Meyer, B. Parametrization of GROMOS force field for oligosaccharides and assessment of efficiency of molecular dynamics simulations. J. Comput. Chem., 1996, 17, 1068-84.
89. Hagler, A. T.; Ewig, C. S. On the use of quantum energy surfaces in the derivation of molecular force fields. Comput. Phys. Commun., 1994, 84, 131-55.
90. Hwang, M.-J.; Stockfisch, T. P.; Hagler, A. T. Derivation of Class II Force Fields. 2. Derivation and Characterization of a Class II Force Field, CFF93, for the Alkyl Functional Group and Alkane Molecules. J. Am. Chem. Soc., 1994, 116, 2515-25.
91. Maple, J. R.; Hwang, M.-J.; Stockfisch, T. P.; Dinur, U.; Waldman, M.; Ewig, C. S.; Hagler, A. T. Derivation of class II force fields. I. Methodology and quantum force field for the alkyl functional group and alkane molecules. J. Comput. Chem., 1994, 15, 162-82.
92. Maple, J. R.; Hwang, M.-J.; Stockfisch, T. P.; Hagler, A. T. Derivation of Class II force fields. III.Characterization of a quantum force field for the alkanes. Israel J. Chem., 1994, 34, 195.
93. Allured, V. S.; Kelly, C. M.; Landis, C. R. SHAPES empirical force field: new treatment of angular potentials and its application to square-planar transition-metal complexes. J. Am. Chem. Soc., 1991, 113, 1-12.
94. Shi, S.; Yan, L.; Yang, Y.; Fisher-Shaulsky, J.; Thacher, T. An extensible and systematic force field, ESFF, for molecular modeling of organic, inorganic, and organometallic systems. J. Comput. Chem., 2003, 24, 1059-76.
95. Patel, S.; Brooks, C. L. CHARMM fluctuating charge force field for proteins: I parameterization and application to bulk organic liquid simulations. J. Comput. Chem., 2004, 25, 1-16.
96. Patel, S.; Mackerell Jr., A. D.; Brooks, C. L. CHARMM fluctuating charge force field for proteins: II Protein/solvent properties from molecular dynamics simulations using a nonadditive electrostatic model. J. Comput. Chem., 2004, 25, 1504-14.
97. Halgren, T. A.; Damm, W. Polarizable force fields.. Curr. Opin. Struct. Biol., 2001, 11, 236-42.
98. Friesner, R. A. Modeling Polarization in Proteins and Protein-ligand Complexes: Methods and Preliminary Results. Adv. Protein Chem., 2005, 72, 79-104.
99. Banks, J. L.; Kaminski, G. A.; Zhou, R.; Mainz, D. T.; Berne, B. J.; Friesner, R. A. Parameterizing a polarizable force field from ab initio data. I. The fluctuating point charge model.. J. Chem. Phys., 1999, 110, 741-54.
100. Stern, H. A.; Kaminski, G. A.; Banks, J. L.; Zhou, R.; Berne, B. J.; Friesner, R. A. Fluctuating charge, polarizable dipole, and combined models:Parameterization from ab initio quantum chemistry.. J. Phys. Chem. B, 1999, 103, 4730-37.
101. Gresh, N.; Guo, H.; Salahub, D. R.; Roques, B. P.; Kafafi, S. A. Critical role of anisotropy for the dimerization energies of two protein-protein recognition motifs: cis-N-methylacetamide versus a beta-sheet conformer of alanine dipeptide. A joint ab initio, density functional theory, and molecular mechanics investigation.. J. Am. Chem. Soc., 1999, 121, 7885-94.
102. Kaminski, G. A.; Stern, H. A.; Berne, B. J.; Friesner, R. A.; Cao, Y. X.; Murphy, R. B.; Zhou, R.; Halgren, T. A. Development of a polarizable force field for proteins via ab initio quantum chemistry: first generation model and gas phase tests. J. Comput. Chem., 2002, 23, 1515-31.
103. Maple, J. R.; Cao, Y.; Damm, W.; Halgren, T. A.; Kaminski, G. A.; Zhang, L. Y.; Friesner, R. A. The Polarizable Force Field and Continuum Solvation Methodology for Modeling of Protein-Ligand Interactions. J. Chem. Theory Comput., 2005, 1, 694-715.
104. Schnieders, M. J.; Baker, N. A.; Ren, P.; Ponder, J. W. Polarizable atomic multipole solutes in a Poisson-Boltzmann continuum. J. Chem. Phys., 2007, 126, 124114.
105. Anisimov, V. M.; Vorobyov, I. V.; Roux, B.; Mackerell, A. D. Polarizable empirical force field for the primary and secondary alcohol series based on the classical Drude model. J. Chem. Theory Comput., 2007, 3, 1927-46.
106. Tan, Y.-H.; Tan, C.; Wang, J.; Luo, R. Continuum Polarizable Force Field within the Poisson-Boltzmann Framework. J. Phys. Chem. B., 2008, 112, 7675-88.
107. Kapetanovic, I. M. Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach. Chem. Biol. Interact., 2008, 171, 165-76.
108. Kishan, K. V. Structural biology, protein conformations and drug designing. Curr. Protein Pept. Sci., 2007, 8, 376-80.
109. Laurie, A. T.; Jackson, R. M. Methods for the prediction of protein-ligand binding sites for structure-based drug design and virtual ligand screening. Curr. Protein Pept. Sci., 2006, 7, 395-406.
110. Ghoshal, N.; Achari, B.; Ghoshal, T. K. Computer aids in drug design - highlights. Pol. J. Pharmacol., 1996, 48, 359-77.
111. Jones, G.; Willett, P. Docking small-molecule ligands into active sites. Curr. Opin. Biotechnol., 1995, 6, 652-6.
112. Gschwend, D. A.; Good, A. C.; Kuntz, I. D. Molecular docking towards drug discovery. J. Mol. Recognit., 1996, 9, 175-86.
113. Shoichet, B. K.; McGovern, S. L.; Wei, B.; Irwin, J. J. Lead discovery using molecular docking. Curr. Opin. Chem. Biol., 2002, 6, 439-46.
114. Taylor, R. D.; Jewsbury, P. J.; Essex, J. W. A review of protein-small molecule docking methods. J. Comput. Aided Mol. Des., 2002, 16, 151-66.
115. Campbell, S. J.; Gold, N. D.; Jackson, R. M.; Westhead, D. R. Ligand binding: functional site location, similarity and docking. Curr. Opin. Struct. Biol., 2003, 13, 389-95.
116. Kroemer, R. T. Molecular modelling probes: docking and scoring. Biochem. Soc. Trans., 2003, 31, 980-4.
117. Krumrine, J.; Raubacher, F.; Brooijmans, N.; Kuntz, I. Principles and methods of docking and ligand design. Methods Biochem. Anal., 2003, 44, 443-76.
118. Kitchen, D. B.; Decornez, H.; Furr, J. R.; Bajorath, J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat. Rev. Drug Discov., 2004, 3, 935-49.
119. Mohan, V.; Gibbs, A. C.; Cummings, M. D.; Jaeger, E. P.; DesJarlais, R. L. Docking: successes and challenges. Curr. Pharm. Des., 2005, 11, 323-33.
120. Coupez, B.; Lewis, R. A. Docking and scoring - theoretically easy, practically impossible? Curr. Med. Chem., 2006, 13, 2995-3003.
121. Sousa, S. F.; Fernandes, P. A.; Ramos, M. J. Protein-ligand docking: current status and future challenges. Proteins, 2006, 65, 15-26.
122. Cavasotto, C. N.; Orry, A. J. Ligand docking and structure-based virtual screening in drug discovery. Curr. Top. Med. Chem., 2007, 7, 1006-14.
123. Hirayama, N. Docking method for drug discovery. Yakugaku Zasshi, 2007, 127, 113-22.
124. Joseph-McCarthy, D.; Baber, J. C.; Feyfant, E.; Thompson, D. C.; Humblet, C. Lead optimization via high-throughput molecular docking. Curr. Opin. Drug Discov. Dev., 2007, 10, 264-74.
125. Joseph-McCarthy, D. Computational approaches to structure-based ligand design. Pharmacol. Ther., 1999, 84, 179-91.
126. Bohm, G. New approaches in molecular structure prediction. Biophys. Chem., 1996, 59, 1-32.
127. Smith, P. A.; Sorich, M. J.; McKinnon, R. A.; Miners, J. O. Pharmacophore and quantitative structure-activity relationship modeling: complementary approaches for the rationalization and prediction of UDP-glucuronosyltransferase 1A4 substrate selectivity. J. Med. Chem., 2003, 46, 1617-26.
128. Dror, O.; Shulman-Peleg, A.; Nussinov, R.; Wolfson, H. J. Predicting molecular interactions in silico: I. A guide to pharmacophore identification and its applications to drug design. Curr. Med. Chem., 2004, 11, 71-90.
129. McInnes, C. Virtual screening strategies in drug discovery. Curr. Opin. Chem. Biol., 2007, 11, 494-502.
130. Reddy, A. S.; Pati, S. P.; Kumar, P. P.; Pradeep, H. N.; Sastry, G. N. Virtual screening in drug discovery - a computational perspective. Curr. Protein Pept. Sci., 2007, 8, 329-51.
131. Sun, H. Pharmacophore-based virtual screening. Curr. Med. Chem., 2008, 15, 1018-24.
132. Dorsey, B. D.; Levin, R. B.; McDaniel, S. L.; Vacca, -. J. P.; Guare, J. P.; Darke, P. L.; Zugay, J. A.; Emini, E. A.; Schleif, W. A.; Quintero, J. C.; Lin, J. H.; Chen, I.-W.; Holloway, M. K.; Fitzgerald, P. M. D.; Axel, M. G.; Ostovic, D.; Anderson, P. S.; Hufl, J. R. L-735,524: The Design of a Potent and Orally Bioavailable HIV Protease Inhibitor. J. Med. Chem., 1994, 37, 3443-51.
133. van't Hoff, J. H. Bull. Soc. Chim., 1875, 23, 295.
134. Le Bel, J. A. Sur les relations qui existent entre les formules atomiques des corps organiques, et le pouvoir rotatoire de leurs. Bull. Soc. Chim., 1874, 22, 337.
135. Barton, D. H. R. The conformation of the steroid nucleus. Experientia, 1950, 6, 316-20.
136. Hassel, O. Q. Rev., 1953, 7, 221.
137. Eisenberg, D.; McLachlan, A. D. Solvation energy in protein folding and binding. Nature, 1986, 319, 199-203.
138. Kang, Y. K.; Nemethy, G.; Scheraga, H. A. Free energies of hydration of solute molecules. 3. Application of the hydration shell model to charged organic molecules. J. Phys. Chem., 1987, 91, 4118-20.
139. Kang, Y. K.; Nemethy, G.; Scheraga, H. A. Free energies of hydration of solute molecules. 1. Improvement of the hydration shell model by exact computations of overlapping volumes. J. Phys. Chem., 1987, 91, 4105-09.
140. Kang, Y. K.; Nemethy, G.; Scheraga, H. A. Free energies of hydration of solute molecules. 2. Application of the hydration shell model to nonionic organic molecules. J. Phys. Chem., 1987, 91, 4109-17.
141. Hasel, W.; Hendrickson, T. F.; Still, W. C. A Rapid Approximation to the Solvent Accessible Surface Areas of Atoms. Tetrahedron. Comput. Method, 1988, 1, 103-16.
142. Ooi, T.; Oobatke, M.; Nemethy, G.; Scheraga, H. A. Accessible surface areas as a measure of the thermodynamic parameters of hydration of peptides. Proc. Natl. Acad. Sci. USA, 1988, 84, 3086-90.
143. Keserü, G.; Kolossváry, I. Molecular Mechanics and Conformational Analysis in Drug Design. Blackwell Science: Oxford, 1999.
144. Metropolis, N.; Rosenbluth, A. W.; Rosenbluth, M. N.; Teller, A. H.; Teller, E. Equation of State Calculations by Fast Computing Machines. J. Chem. Phys., 1953, 21, 1087.
145. Buckingham, J.; Glen, R. C.; Hill, A. P.; Hyde, R. M.; Martin, G. R.; Robertson, A. D.; Salmon, J. A.; Woollard, P. M. Computer-Aided Design and Synthesis of 5-Substituted Tryptamines and Their Pharmacology at the 5-HT1D Receptor: Discovery of Compounds with Potential Anti-Migraine Properties. J. Med. Chem., 1995, 38, 3566-80.
146. Zwanzig, R. W. High temperature equation of state by a perturbation method. J. Chem. Phys., 1954, 22, 1420-26.
147. Kamath, S. A.; Desai, P. M.; Coutinho, E. C. Calculation of relative binding free energy difference of DHFR inhibitors by a Finite Difference Thermodynamic Integration (FDTI) Approach. J. Biomol. Struct. Dyn., 1999, 16, 1239-44.
148. Waszkowycz, B. Structure-based approaches to drug design and virtual screening. Curr. Opin. Drug Discov. Dev., 2002, 5, 407-13.
149. Marrone, T. J.; Briggs, J. M.; McCammon, J. A. Structure-based drug design: computational advances. Annu. Rev. Pharmacol. Toxicol., 1997, 37, 71-90.
150. Anderson, A. C.; Wright, D. L. The Design and Docking of Virtual Compound Libraries to Structures of Drug Targets. Curr. Comput. Aided Drug Des., 2005, 1, 103-27
151. Eldridge, M. D.; Murray, C. W.; Auton, T. R.; Paolini, G. V.; Mee, R. P. Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. J. Comput. Aid. Mol. Des., 1997, 11, 425-45.
152. Muegge, I.; Martin, Y. C. A General and Fast Scoring Function for Protein-Ligand Interactions: A Simplified Potential Approach. J. Med. Chem., 1999, 42 791-804.
153. Laurie, T.; Jackson, R. M. Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites. Bioinformatics, 2005, 21, 1908-16.
154. Goodford, P. J. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J. Med. Chem., 1985, 28, 849-57.
155. Goodford, P. In: Molecular Interaction Fields; Prof. Dr. Gabriele, C., Ed.: 2006; pp. 1-25.
156. Goodford, P. Multivariate characterization of molecules for QSAR analysis. J. Chemometr., 1996, 10, 107-17.
157. Jackson, R. C. Update on computer-aided drug design. Curr. Opin. Biotechnol., 1995, 6, 646-51.
158. Böhm, H.-J. A novel computational tool for automated structure-based drug design. J. Mol. Recognit., 1993, 6, 131-37.
159. Böhm, H.-J. On the use of LUDI to search the Fine Chemicals Directory for ligands of proteins of known three-dimensional structure J. Comput. Aided. Mol. Des., 1994, 8, 243-56.
160. Böhm, H.-J. Prediction of binding constants of protein ligands: A fast method for the prioritization of hits obtained from de novo design or 3D database search programs J. Comput. Aided Mol. Des., 1998, 12, 303-23.
161. Meng, E. C.; Kuntz, I. D.; Abraham, D. J.; Kellogg, G. E. Evaluating docked complexes with the HINT exponential function and empirical atomic hydrophobicities. J. Comput. Aided Mol. Des., 1994, 8, 299-306.
162. Sperandio, O.; Miteva, M. A.; Delfaud, F.; Villoutreix, B. O. Receptor-based computational screening of compound databases: the main docking-scoring engines. Curr. Protein Pept. Sci., 2006, 7, 369-93.
163. SYBYL, Chemical Information Software; Tripos, Inc.: St. Louis, MO.
164. Wang, R.; Lai, L.; Wang, S. Further Development and Validation of Empirical Scoring Functions for Structure-Based Binding Affinity Prediction. J. Comput. Aided Mol. Des., 2002, 16, 11-26.
165. Wang, R.; Lu, Y.; Wang, S. Comparative Evaluation of 11 Scoring Functions for Molecular Docking. J. Med. Chem., 2003, 46, 2287-303.
166. Wang, R.; Wang, S. J. How Does Consensus Scoring Work for Virtual Library Screening? An Idealized Computer Experiment. Chem. Inf. Comput. Sci., 2001, 41, 1422-26.
167. Wang, R.; Gao, Y.; Lai, L. Calculating partition coefficient by atom-additive method. Perspectives in Drug Discovery and Design. Persp. Drug Dis. Des., 2000, 19, 47-66.
168. Verdonk, M. L.; Cole, J. C.; Hartshorn, M. J.; Murray, C. W.; Taylor, R. D. Improved protein-ligand docking using GOLD. Proteins, 2003, 52, 609-23.
169. Ewing, T. J. A.; Kuntz, I. D. Critical evaluation of search algorithms for automated molecular docking and database screening. J. Comput. Chem., 1997, 18 1175-89.
170. Ewing, T. J. A.; Makino, S.; Skillman, A. G.; Kuntz, I. D. DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases. J. Comput. Aided Mol. Des., 2001, 15, 411-28.
171. Goodsell, D. S.; Morris, G. M.; Olson, A. J. Automated docking of flexible ligands: applications of AutoDock. J. Mol. Recognit., 1996, 9, 1-5.
172. Jones, G.; Willett, P.; Glen, R. C.; Leach, A. R.; Taylor, R. Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol., 1997, 267, 727-48.
173. Fogel, G. B.; Cheung, M.; Pittman, E.; Hecht, D. Modeling the inhibition of quadruple mutant Plasmodium falciparum dihydrofolate reductase by pyrimethamine derivatives. J. Comput. Aided Mol. Des., 2008, 22, 29-38.
174. Cramer, R. D.; Patterson, D. E.; Bunce, J. D. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc., 1988, 110, 5959-67.
175. Cramer, R. D., 3rd; Patterson, D. E.; Bunce, J. D. Recent advances in comparative molecular field analysis (CoMFA). Prog. Clin. Biol. Res., 1989, 291, 161-65.
176. Klebe, G.; Abraham, U. On the prediction of binding properties of drug molecules by comparative molecular field analysis. J. Med. Chem., 1993, 36, 70-80.
177. Kim, K. H.; Greco, G.; Novellino, E.; Silipo, C.; Vittoria, A. Use of the hydrogen bond potential function in a comparative molecular field
178. Kellogg, G. E.; Semus, S. F.; Abraham, D. J. HINT: a new method of empirical hydrophobic field calculation for CoMFA. J. Comput. Aided Mol. Des., 1991, 5, 545-52.
179. Silverman, B. D.; Platt, D. E. Comparative molecular moment analysis (CoMMA): 3D-QSAR without molecular superposition. J. Med. Chem., 1996, 39, 2129-40.
180. Silverman, B. D. Three-dimensional moments of molecular property fields. J. Chem. Inf. Comput. Sci., 2000, 40, 1470-76.
181. Robinson, D. D.; Winn, P. J.; Lyne, P. D.; Richards, W. G. Self-organizing molecular field analysis: a tool for structure-activity studies. J. Med. Chem., 1999, 42, 573-83.
182. Korhonen, S. P.; Tuppurainen, K.; Laatikainen, R.; Perakyla, M. Improving the performance of SOMFA by use of standard multivariate methods. SAR QSAR Environ. Res., 2005, 16, 567-79.
183. Silber, K.; Heidler, P.; Kurz, T.; Klebe, G. AFMoC enhances predictivity of 3D QSAR: a case study with DOXP-reductoisomerase. J. Med. Chem., 2005, 48, 3547-63.
184. Gohlke, H.; Klebe, G. DrugScore meets CoMFA: adaptation of fields for molecular comparison (AFMoC) or how to tailor knowledge-based pair-potentials to a particular protein. J. Med. Chem., 2002, 45, 4153-70.
185. Datar, P.; Desai, P.; Coutinho, E.; Iyer, K. CoMFA and CoMSIA studies of angiotensin (AT1) receptor antagonists. J. Mol. Model., 2002, 8, 290-301.